Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

Clinical trial NCT03615911 · COMPLETED

Trial details

NCT number: NCT03615911
Sponsor: Marylyn Addo
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

MERS (Middle East Respiratory Syndrome)

Start date: 2017-11-28
Primary completion: 2019-04-15
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.